insights_auto
Why is TGTX down 2.01%?
Dive Deeperchevron_right
TGTX:NASDAQ
TG Therapeutics Inc common stock
$59.95
arrow_downward
-2.01%(-1.23) 1D
$59.93
arrow_downward
-0.03% (-0.020)bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$61.01
High
$63.60
Low
$59.59
Mkt. cap
9.18B
Avg. vol.
1.61M
Volume
2.58M
P/E ratio
21.84
52-wk high
$63.60
52-wk low
$26.76
EPS
$2.75
Beta
1.80
Shares outstanding
153.07M
No. of employees
399
Open
$61.01
High
$63.60
Low
$59.59
Mkt. cap
9.18B
Avg. vol.
1.61M
Volume
2.58M
P/E ratio
21.84
52-wk high
$63.60
52-wk low
$26.76
EPS
$2.75
Beta
1.80
Shares outstanding
153.07M
No. of employees
399
News stories
From web sources and news partners
Zacks
·
10 hours ago
ETON Gears Up to Report Q3 Earnings: What Can Investors Expect?
Traders Union
·
14 hours ago
TG Therapeutics hosts Q3 2026 earnings call after stock ends session up 5.2%
Zacks
·
14 hours ago
Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?
TG Therapeutics
·
14 hours ago
TG Therapeutics to Host Conference Call on Third Quarter 2026 Financial Results and Business Update
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorBiotechnology
Websitetgtherapeutics.com